esthesioneuroblastoma

Olfactory neuroblastomas, also known as esthesioneuroblastomas, (the spelling aesthesioneuroblastoma is archaic) are tumors arising from the basal layer of the olfactory epithelium in the superior recess of the nasal cavity.

They usually present as a soft tissue mass in the superior olfactory recess involving the anterior and middle ethmoid air-cells on one side and extending through the cribriform plate into the anterior cranial fossa. Contrast enhancement is often marked in both CT and MRI studies.

Epidemiology

There is bimodal age distribution with one peak in young adult patients (~2 decade) and another peak in the 5 to 6 decades. There is no recognized gender predilection.

Clinical presentation

Clinical presentation is usually secondary to nasal stuffiness and rhinorrhea or epistaxis. Presentation is often delayed and symptoms may have been present for many months. Patients often present late with larger tumors which can extend into the intracranial compartment (25-30% at diagnosis) and usually result in anosmia .

Pathology

Olfactory neuroblastomas are of neural crest cell origin . Macroscopically, they are multilobulated pink-grey tumors.

Histology demonstrates variable differentiation, from well-formed neural tissue to undifferentiated neuroblasts with pseudorosette formation . It has been suggested that olfactory neuroblastoma is actually part of the Ewing sarcoma group of tumors, rather than being related to neuroblastoma .

Staging

See: olfactory neuroblastoma staging

Radiographic features

The tumors are slow-growing and the choice of imaging will depend on the tumor's size. They begin as masses in the superior olfactory recess and initially involve the anterior and middle ethmoid air-cells unilaterally . As they grow, they tend to destroy surrounding bone and can extend in any direction. Often they are said to form a "dumbbell-shaped" mass with a "waist" as it passes through the cribriform plate .

This invasion may be superiorly into the anterior cranial fossa, laterally into the orbits and across the midline into the contralateral nasal cavity. They can also obstruct the ostia of paranasal sinuses, resulting in opacification of the sinus with secretions .

Particular attention should be paid to the presence of cervical and retropharyngeal nodal metastases, which are present in 10-44% of cases at diagnosis .

CT

CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region . The mass is of soft tissue attenuation, with relatively homogeneous enhancement . Focal calcifications are occasionally present .

These tumors are relatively slow-growing and thus, bony margins are often remodeled and resorbed, rather than being aggressively destroyed .

MRI

Signal characteristics include:

• T1: heterogeneous intermediate signal
• T2: heterogeneous intermediate signal
• T1 C+ (Gd): variable enhancement (usually moderate to intense)

When an intracranial extension is present, peritumoural cysts between it and the overlying brain are often present. This may be helpful in distinguishing it from other entities (see below) . The margins of these cysts sometimes enhance .

Angiography/DSA

Angiography demonstrates a prominent tumor blush with arteriovenous shunting and persistent opacification.

Nuclear medicine

As with other neuroblastomas, olfactory neuroblastomas are MIBG-avid. This potentially helps to differentiate them from other tumors that arise in region .

Treatment and prognosis

Treatment usually involves combined chemotherapy and/or radiotherapy with surgical excision. Prognosis is significantly affected by the presence of distant metastases (see olfactory neuroblastoma staging).

• no distant metastases: 60% 5-year survival
• distant metastases: 0% 5-year survival

Small localized tumors have a high cure rate, up to 85-90% .

Differential diagnosis

Unfortunately, imaging alone often struggles to distinguish between olfactory neuroblastomas and other aggressive malignancies in the region. The differential includes :

• olfactory neuroepithelioma
  • rare and indistinguishable on imaging
• olfactory groove meningioma/hemangiopericytoma
  • especially if superior extension
• sinonasal carcinoma (including SCC, minor salivary gland adenocarcinoma)
  • may appear identical
  • usually older patients
  • lack peritumoural cysts
• rhabdomyosarcoma
• melanoma metastases
• lymphoma
  • may appear identical
  • lack peritumoural cysts
• nasopharyngeal carcinoma
  • epicenter more posteriorly located
  • usually older patients
• chordoma
  • epicenter more posteriorly located
  • high T2 signal
• pituitary macroadenoma
  • epicenter more posteriorly located
• juvenile nasopharyngeal angiofibroma
  • epicenter more posteroinferiorly located
  • almost exclusively in males
  • often somewhat younger

Siehe auch:

• Meningeom
• Chordom
• Makroadenom Hypophyse
• Rhabdomyosarkom
• Hämangioperizytom
• Juveniles Angiofibrom
• Nasopharynxkarzinom
• nasopharyngeal epithelioma
• kadish staging of olfactory neuroblastoma
• Neuroepitheliom des N. olfactorius
• primäres intrakraniales Neuroblastom

und weiter:

• Hyperostosis Kalotte
• MIBG
• Choanalpolyp
• Invertiertes Papillom
• neuroradiologisches Curriculum
• ACP
• esthesioneuroblastoma staging
• esthesioneuroblastoma with pulmonary and pleural metastases
• neuroblastische Tumoren